Cargando…

The need to further understand who gets hospitalized for a COPD exacerbation

Detalles Bibliográficos
Autores principales:	Maselli, Diego J, Anzueto, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3436668/ https://www.ncbi.nlm.nih.gov/pubmed/22958418 http://dx.doi.org/10.1186/2049-6958-7-7

Ejemplares similares

Optimizing bronchodilation in the prevention of COPD exacerbations
por: Miravitlles, Marc, et al.
Publicado: (2017)

Handgrip strength during admission for COPD exacerbation: impact on further exacerbation risk
por: Lee, Chi-Tai, et al.
Publicado: (2021)

Determinants of exacerbation risk in patients with COPD in the TIOSPIR study
por: Calverley, Peter MA, et al.
Publicado: (2017)

Understanding variation in length of hospital stay for COPD exacerbation: European COPD audit
por: Ruparel, Mamta, et al.
Publicado: (2016)

Treatment of exacerbations as a predictor of subsequent outcomes in patients with COPD
por: Calverley, Peter MA, et al.
Publicado: (2018)

Factors associated with change in exacerbation frequency in COPD
por: Donaldson, Gavin C, et al.
Publicado: (2013)

A clinical prediction model for hospitalized COPD exacerbations based on “treatable traits”
por: Yii, Anthony C A, et al.
Publicado: (2019)

Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes
por: Anzueto, A, et al.
Publicado: (2009)

Korean COPD Patients Can Get Satisfaction
por: Rhee, Chin Kook
Publicado: (2022)

Community-Acquired Respiratory Complications in the Intensive Care Unit: Pneumonia and Acute Exacerbations of COPD
por: Restrepo, M. I., et al.
Publicado: (2010)

Deprivation, winter season, and COPD exacerbations
por: Donaldson, Gavin C, et al.
Publicado: (2013)

Seasonal variations in exacerbations and deaths in patients with COPD during the TIOSPIR(®) trial
por: Wise, Robert A, et al.
Publicado: (2018)

A score to predict short-term risk of COPD exacerbations (SCOPEX)
por: Make, Barry J, et al.
Publicado: (2015)

Prednisolone for COPD exacerbations: time for a rethink
por: Ramakrishnan, Sanjay
Publicado: (2023)

Prognostic factors for clinical failure of exacerbations in elderly outpatients with moderate-to-severe COPD
por: Wilson, Robert, et al.
Publicado: (2015)

Impact of statins and ACE inhibitors on mortality after COPD exacerbations
por: Mortensen, Eric M, et al.
Publicado: (2009)

Is gastro-oesophageal reflux associated with COPD exacerbations?
por: Wedzicha, Jadwiga A.
Publicado: (2013)

Pneumonia in exacerbations of COPD: what is the clinical significance?
por: Trethewey, Samuel P., et al.
Publicado: (2020)

A novel study design for antibiotic trials in acute exacerbations of COPD: MAESTRAL methodology
por: Wilson, Robert, et al.
Publicado: (2011)

Detransition needs further understanding, not controversy
por: MacKinnon, Kinnon Ross, et al.
Publicado: (2023)

The effect of COPD severity and study duration on exacerbation outcome in randomized controlled trials
por: Eriksson, Göran, et al.
Publicado: (2017)

Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results
por: Wilson, Robert, et al.
Publicado: (2012)

Mortality and Exacerbation Risk by Body Mass Index in Patients with COPD in TIOSPIR and UPLIFT
por: Putcha, Nirupama, et al.
Publicado: (2022)

Revisiting the Use of Antibiotics to Prevent COPD Exacerbation: Is Doxycycline the Answer?
por: Adrish, Muhammad, et al.
Publicado: (2023)

Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations
por: Calverley, Peter M, et al.
Publicado: (2016)

Further progress in understanding of myofibrillar function in health and disease
por: Cremo, Christine, et al.
Publicado: (2021)

General practice needs further development of theoretical knowledge
por: Braut, Geir Sverre, et al.
Publicado: (2019)

Information Needs in COPD After an Educational Programme: Influence in Exacerbations and Admissions
por: Amado, Carlos Antonio, et al.
Publicado: (2020)

Triple therapy in COPD: understanding the data
por: Suissa, Samy
Publicado: (2023)

The Americas need to get back on track with immunisation campaigns
por: Regional Health– Americas, The Lancet
Publicado: (2022)

Emotional processing needs further study in major psychiatric diseases
por: Thibaut, Florence
Publicado: (2015)

Getting stuck or choosing to stay? Neutrophil transit times in the lung in acute inflammation and COPD
por: Sapey, Elizabeth, et al.
Publicado: (2019)

Predicting Re-Exacerbation Timing and Understanding Prolonged Exacerbations: An Analysis of Patients with COPD in the ECLIPSE Cohort
por: Meeraus, Wilhelmine H, et al.
Publicado: (2021)

Exacerbations of COPD
por: Pavord, Ian D, et al.
Publicado: (2016)

Exacerbations of COPD
por: Viniol, Christian, et al.
Publicado: (2018)

Antibiotic Prescription for COPD Exacerbations Admitted to Hospital: European COPD Audit
por: López-Campos, Jose Luis, et al.
Publicado: (2015)

Predicting and preventing hospital readmission for exacerbations of COPD
por: Kong, Chia Wei, et al.
Publicado: (2020)

The need for a national perspective to improve COPD management
por: Marco, Fabiano Di, et al.
Publicado: (2019)

Who needs an editor?
por: Westgarth, David
Publicado: (2023)

Role of Bile Reflux in Functional Dyspepsia: Areas That Need Further Research
por: Kang, Seung Joo
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fq2a8rpp0d400mro53ll4vrtrn